Israel Englander’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63M Sell
347,920
-313,300
-47% -$3.5M ﹤0.01% 3308
2026
Q1
$7.87M Buy
661,220
+108,543
+20% +$1.11M ﹤0.01% 2419
2025
Q4
$5.5M Buy
552,677
+366,566
+197% +$3.5M ﹤0.01% 2898
2025
Q3
$1.67M Buy
186,111
+171,439
+1,168% +$1.59M ﹤0.01% 4213
2025
Q2
$138K Sell
14,672
-65,727
-82% -$580K ﹤0.01% 5464
2025
Q1
$872K Buy
+80,399
New +$809K ﹤0.01% 4459
2024
Q4
Sell
-3,216,041
Closed -$32.5M 5907
2024
Q3
$36.1M Buy
3,216,041
+2,701,054
+524% +$28.7M 0.02% 1054
2024
Q2
$5.15M Sell
514,987
-2,634
-0.5% -$26.8K ﹤0.01% 2697
2024
Q1
$5.96M Buy
517,621
+486,150
+1,545% +$4.13M ﹤0.01% 2707
2023
Q4
$229K Buy
31,471
+13,791
+78% +$109K ﹤0.01% 5110
2023
Q3
$161K Sell
17,680
-32,672
-65% -$392K ﹤0.01% 5200
2023
Q2
$613K Sell
50,352
-355,146
-88% -$3.96M ﹤0.01% 4402
2023
Q1
$5.04M Sell
405,498
-380,633
-48% -$7M ﹤0.01% 2599
2022
Q4
$15.1M Buy
786,131
+645,281
+458% +$13.6M 0.01% 1705
2022
Q3
$2.65M Sell
140,850
-1,475,502
-91% -$30.3M ﹤0.01% 3496
2022
Q2
$29.2M Buy
1,616,352
+677,889
+72% +$11M 0.02% 979
2022
Q1
$15M Sell
938,463
-30,478
-3% -$548K 0.01% 1678
2021
Q4
$23.7M Buy
968,941
+661,469
+215% +$15.5M 0.01% 1291
2021
Q3
$7.16M Buy
307,472
+299,522
+3,768% +$7.24M ﹤0.01% 2459
2021
Q2
$218K Buy
+7,950
New +$227K ﹤0.01% 5962
2021
Q1
Sell
-506,872
Closed -$19M 5852
2020
Q4
$19M Buy
506,872
+343,258
+210% +$10.6M 0.01% 1104
2020
Q3
$3.57K Buy
163,614
+144,477
+755% +$3.03M ﹤0.01% 2122
2020
Q2
$308K Sell
19,137
-110,324
-85% -$1.84M ﹤0.01% 3648
2020
Q1
$2.07M Buy
129,461
+78,626
+155% +$1.11M ﹤0.01% 1987
2019
Q4
$558K Buy
+50,835
New +$505K ﹤0.01% 3318

Other funds holding AHCO

Israel Englander's AHCO Position: Q2 2026 in Review

Israel Englander reduced its AdaptHealth (AHCO) stake by 47% in Q2 2026, selling an estimated $3.5M and leaving 347,920 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3308.

Israel Englander first reported a position in AHCO in Q4 2019 and has held it in 25 quarters since. The position peaked at $36.1M in Q3 2024. 237 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Israel Englander held 347,920 shares of AdaptHealth worth $3.63M as of Q2 2026.
  • Israel Englander sold 313,300 AdaptHealth shares in Q2 2026, an estimated $3.5M.
  • AdaptHealth made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3308 holding.
  • Israel Englander first reported a position in AdaptHealth in Q4 2019 and has held it in 25 quarters since.
  • Israel Englander's AdaptHealth position peaked at $36.1M in Q3 2024.
  • 237 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.